| Fund Name | Location |
| DCapital | - |
| EDS-A.T. Kearney Ventures | - |
| Flyinghealth | Berlin, Berlin, Germany |
| Hayan Health Networks | California, San Francisco, United States |
| KLEOSS Capital | Gauteng, Johannesburg, South Africa |
| Kudan | Japan, Tokyo |
| L'Occitane en Provence | Geneva, Plan-les-ouates, Switzerland |
| M Capital Partners | France, Midi-Pyrenees, Toulouse |
| Maroon Bells Capital Partners | California, San Francisco, United States |
| North Ridge Partners | Central, Central Region, Singapore |
| Rex Health Ventures | North Carolina, Raleigh, United States |
| Shenzhen Bingchuan Network | China, Guangdong, Tianjin |
| Syndicat Technologies | - |
| Taihe Capital | Beijing, Beijing, China |
| TechAngels | Bucharest, Bucuresti, Romania |
| Tri-State Investment Group | Chapel Hill, North Carolina, United States |
| Valliance Capital | - |
| Werth Family Investment Associates | - |
| Xinbaiyi | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ansun BioPharma | $85M | 14 May 2018 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ansun BioPharma | $85M | 14 May 2018 | San Diego, California, United States |
